Demography is destiny: forecasting a bright future for home care and hospice.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to D Berke.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The National Association for Home Care (NAHC), its members agencies, and affiliated state associations have launched an aggressive campaign to educate Congress and others about the harmful effects of Interim Payment System. One way is through NAHC's Blueprints for Action--NAHC's action plan for 1998.
Explore the source record for details and available documents.
The home care industry has proposed a unified plan for prospective payment. Providers, however, are still unclear about what factors are involved and what will change for them under this plan. This article answers some of the most common questions.
Congress passed the Ryan White Act in 1990, yet its funding does not meet authorized levels. While the Act is a fine start in battling the AIDS epidemic, NAHC and the National Organizations Responding to AIDS (NORA), of which NAHC is a member, urge full funding of the Act as well as expanded home and community-based programs under the Act and other federal and state programs.
The special problems that home care providers face in delivering health care in rural and frontier areas, including poor accessibility, increased travel times, and staffing shortages, make providing quality and efficient service a challenge.
Significant and varied legislation relating to the AIDS crisis has been passed, and much remains pending for further debate. These measures, in various stages of the legislative process, affect PWAs and those who come into contact with the health care system.
The inclusion of home IV drug therapy in the Medicare Catastrophic Coverage Act of 1988 brought IV therapy issues to the attention of regulators and providers. Although the legislation was revoked, the issues that were raised in its development must be addressed under the current programs and in any future home IV therapy legislation.